Equities

Polygiene Group AB

Polygiene Group AB

Actions
  • Price (SEK)10.50
  • Today's Change-0.20 / -1.87%
  • Shares traded49.40k
  • 1 Year change+77.97%
  • Beta1.7094
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments444853
Total Receivables, Net274539
Total Inventory303628
Prepaid expenses2.123.161.25
Other current assets, total------
Total current assets103132121
Property, plant & equipment, net5.342.232.69
Goodwill, net186461407
Intangibles, net12126.09
Long term investments0----
Note receivable - long term07.019.46
Other long term assets------
Total assets314622551
LIABILITIES
Accounts payable7.391311
Accrued expenses9.939.469.63
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.011.622.38
Other current liabilities, total1.334.968.23
Total current liabilities212932
Total long term debt1.880.020.02
Total debt3.891.642.40
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities232932
SHAREHOLDERS EQUITY
Common stock3.653.653.56
Additional paid-in capital------
Retained earnings (accumulated deficit)(235)6641
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total523523475
Total equity291593519
Total liabilities & shareholders' equity314622551
Total common shares outstanding373736
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.